Neuritek Therapeutics Inc — Form C (Regulation Crowdfunding)
Neuritek Therapeutics Inc of NEW YORK, NY filed a Form C (Regulation Crowdfunding) with the SEC on 2024-09-04. Target raise $15K, up to $1.2M. Offered through StartEngine Capital, LLC.
Offering
- Filed: 2024-09-04
- Form: C
- Accession: 0001665160-24-001263
- Target amount: $15K
- Maximum amount: $1.2M
- Security type: Common Stock
- Securities offered: 10,000
- Price: $1.5000
- Deadline: 2024-12-03
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007
Issuer
- CIK: 0002036176
- Website: https://www.neuritek.com/
- Legal status: Corporation
- Organized in: NY
- Incorporated: 2019-01-28
- Address: 5 East 57th Street, 18th FL, NEW YORK, NY, 10022
- Employees: 2
Financials (as filed)
- Net income (most recent): $101K
- Short-term debt: $2K
People (2)
| Name | Role | Location |
|---|
| William Emery Hapworth | Chairman of the Board | NEW YORK, NY |
| William Allan Bradley | CEO/CFO and Director | NEW YORK, NY |
Reg CF filing history (2)
More